Category: Genomics
Global Genomics
-
Growth Factors (Blood and Tissue)
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Interferons, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$78.2 Billion by ... Read More
-
Animal Genetics
... CAGR of 5.8% over the analysis period 2024-2030. Live Animals, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$7.3 Billion by the end of the analysis ... Read More
-
Electron Microscopy and Sample Preparation
... Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Industrial, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$3.2 Billion by ... Read More
-
Genomics
... 19.0% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$106.1 Billion by the end of the analysis period. Growth in ... Read More
-
Sample Preparation
... CAGR of 4.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
Genetic Testing
... CAGR of 9.9% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$13.6 Billion by the end of the analysis period. ... Read More
-
Glycomics / Glycobiology
... at a CAGR of 16.9% over the analysis period 2024-2030. Enzymes, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
RNA Analysis / Transcriptomics
... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by ... Read More
-
Gene Amplification Technologies
... at a CAGR of 10.0% over the analysis period 2024-2030. Medical & Pharma, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.4 Billion by the end ... Read More
-
Human Identification
... CAGR of 7.7% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
microRNA (miRNA)
... CAGR of 13.1% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$411.8 Million by the end of the analysis period. ... Read More
-
Competent Cells
... CAGR of 7.8% over the analysis period 2024-2030. Cloning, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.9 Billion by ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Transcriptomics Technologies
... CAGR of 7.2% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.7 Billion by the end of the analysis period. ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$28.1 Billion by the end of the analysis period. ... Read More
-
Small Molecule Kinase Inhibitors
... 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$27.8 Billion While China is Forecast to Grow at 14.6% CAGR The Small Molecule Kinase Inhibitors market ... Read More
-
Agrigenomics
... 8.1% over the analysis period 2024-2030. Crops, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... the year 2024, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Biochips & Microarrays, one of the segments analyzed in the report, is expected ... Read More
-
Microbiome Sequencing Services
... at a CAGR of 18.2% over the analysis period 2024-2030. Synthesis, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the ... Read More
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
... to the advantage that these assay kits offer standardized and optimized protocols, facilitating accurate and efficient analysis of biomarkers in various biological samples, thus contributing significantly to diagnostic and research endeavors in healthcare. Further, advances ... Read More
-
NLP in Healthcare & Life Sciences Market by NLP Technique (OCR, NER, Sentiment Analysis), Application (Genomics & Precision Medicine, Patient Care & Engagement, Clinical Operations & Decision Support, Biomedical Research) - Global Forecast to 2030
... the forecast period. The substantial increase in unstructured clinical data, including electronic health records, physician notes, and pathology reports, drives the demand for NLP technologies to derive actionable insights. Simultaneously, clinical decision support is gaining ... Read More
-
Global Multiomics Market, By Product & Service (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as ... Read More
-
Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030
... 2030. Apart from the growth of the pharmaceutical and biotech sectors and the wide use of high-throughput screening (HTS) methods, greater emphasis on data accuracy and precision within scientific workflows and the ongoing development of ... Read More
Research Assistance
